» Articles » PMID: 22251938

New Criteria for Histologic Grading of Colorectal Cancer

Overview
Date 2012 Jan 19
PMID 22251938
Citations 95
Authors
Affiliations
Soon will be listed here.
Abstract

Conventional tumor grading systems based on the degree of tumor differentiation may not always be optimal because of difficulty in objective assessment and insufficient prognostic value for decision making in colorectal cancer (CRC) treatment. This study aimed to determine the importance of assessing the number of poorly differentiated clusters as the primary criterion for histologic grading of CRC. Five hundred consecutive patients with curatively resected stage II and III CRCs (2000 to 2005) were pathologically reviewed. Cancer clusters of ≥5 cancer cells and lacking a gland-like structure were counted under a ×20 objective lens in a field containing the highest number of clusters. Tumors with <5, 5 to 9, and ≥10 clusters were classified as grade (G)1, G2, and G3, respectively (n=156, 198, and 146 tumors, respectively). Five-year disease-free survival rates were 96%, 85%, and 59% for G1, G2, and G3, respectively (P<0.0001). Poorly differentiated clusters affected survival outcome independent of T and N stages and could help in more effective stratification of patients by survival outcome compared with tumor staging (Akaike information criterion, 1086.7 vs. 1117.0; Harrell concordance index, 0.73 vs. 0.67). The poorly differentiated cluster-based grading system showed a higher weighted κ coefficient for interobserver variability (5 observers) compared with conventional grading systems (mean, 0.66 vs. 0.52; range, 0.55 to 0.73 vs. 0.39 to 0.68). Our novel histologic grading system is expected to be less subjective and more informative for prognostic prediction compared with conventional tumor grading systems and TNM staging. It could be valuable in determining individualized postoperative CRC treatment.

Citing Articles

Evaluation of Applicability of Tumor Budding and Poorly Differentiated Clusters as Additional Prognostic Markers in Colorectal Cancers.

Sarkar S, Guha R, Chakrabarti S South Asian J Cancer. 2025; 13(4):315-319.

PMID: 40060345 PMC: 11888805. DOI: 10.1055/s-0044-1788050.


Self-supervised learning reveals clinically relevant histomorphological patterns for therapeutic strategies in colon cancer.

Liu B, Polack M, Coudray N, Claudio Quiros A, Sakellaropoulos T, Le H Nat Commun. 2025; 16(1):2328.

PMID: 40057490 PMC: 11890774. DOI: 10.1038/s41467-025-57541-y.


Optimizing Prognostic Assessment in High-Risk Head and Neck Squamous Cell Carcinomas: The Impact of Tumor Budding and a Novel Histomorphological Scoring System.

Knebel M, Kuhn J, Korner S, Braun F, Brust L, Wemmert S Cancer Med. 2025; 14(4):e70685.

PMID: 39953822 PMC: 11829162. DOI: 10.1002/cam4.70685.


Comparison of the prognosis and lymph node metastasis between no tumor budding and low-grade tumor budding in T1 and T2 colorectal cancer.

Lee J, Roh M, Lee J, Park S, Chang H, Jung S Sci Rep. 2025; 15(1):212.

PMID: 39747554 PMC: 11696688. DOI: 10.1038/s41598-024-84035-6.


Prognostic value of isolated tumor cells and micrometastasis of lymph nodes in invasive urinary bladder cancer.

Cheong H, Yoo Y, Sung S, Park S, Lee D, Kong K PLoS One. 2024; 19(10):e0302445.

PMID: 39453924 PMC: 11508444. DOI: 10.1371/journal.pone.0302445.